Heart failure and diabetes mellitus: epidemiology and management of an alarming association

Journal of Cardiac Failure
Alain Cohen-SolalDamien Logeart

Abstract

Diabetes mellitus is a growing epidemic with a prevalence among patients with heart failure (HF) approaching 30%. Diabetes worsens the prognosis of HF, and the pathophysiology is complex and multifactorial. Early detection of subtle alterations in cardiac function by modern tools, such as Doppler echocardiography or brain natriuretic peptide dosage, is thus important in these patients. All drugs known to be effective in HF with systolic dysfunction are also effective in patients with diabetes. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists also seem particularly useful. Overall, however, little is known about the treatment of diabetic patients with HF, especially in case of preserved systolic function. Ongoing and future trials should help to determine the best treatment for these patients with or without associated diabetes. This review assesses the relationships between diabetes mellitus and HF and discusses the various medical strategies.

References

May 11, 1979·JAMA : the Journal of the American Medical Association·W B Kannel, D L McGee
May 13, 1999·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·A VolkK Rett
Jun 18, 1999·Diabetes Care·M StangD Butler-Jones
Apr 12, 2000·Kidney International·C DelcayreV Robert
Nov 15, 2000·The American Journal of Cardiology·W Doehner, S D Anker
Aug 30, 2001·American Heart Journal·H WedelUNKNOWN MERIT-HF Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Sep 22, 2001·The New England Journal of Medicine·H H ParvingUNKNOWN Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group
Oct 26, 2001·JAMA : the Journal of the American Medical Association·S YusufUNKNOWN HOPE Study Investigators
Jan 5, 2002·The New England Journal of Medicine·J N CohnUNKNOWN Valsartan Heart Failure Trial Investigators
Jul 3, 2002·Annals of Internal Medicine·Dmitri KirpichnikovJames R Sowers
Aug 27, 2002·Journal of Hypertension·Lars H LindholmUNKNOWN LIFE study group
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Jan 9, 2003·JAMA : the Journal of the American Medical Association·Margaret M RedfieldRichard J Rodeheffer
Mar 12, 2003·Circulation·J Malcolm O ArnoldUNKNOWN HOPE Investigators
Mar 14, 2003·European Heart Journal·J G F ClelandUNKNOWN Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology
Mar 14, 2003·European Heart Journal·M KomajdaUNKNOWN Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology
Mar 20, 2003·Current Diabetes Reports·Dmitri Kirpichnikov, James R Sowers
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Apr 19, 2003·Circulation Research·David A Kass
Aug 30, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Jing LiuAshwani Malhotra
Sep 6, 2003·Journal of the American College of Cardiology·Michael DomanskiUNKNOWN BEST Investigators
Sep 19, 2003·Lancet·Marc A PfefferUNKNOWN CHARM Investigators and Committees
Sep 19, 2003·Lancet·K M Fox, UNKNOWN EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
Oct 30, 2003·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Sunder MudaliarRobert R Henry

❮ Previous
Next ❯

Citations

Oct 18, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Buntaro FujitaChristian Jung
Jun 3, 2009·Current Heart Failure Reports·Patrick M Heck, David P Dutka
Aug 13, 2011·Expert Reviews in Molecular Medicine·Asma EjazLeena Pradhan
Jul 14, 2010·Age and Ageing·Kornelis J J van HaterenHenk J G Bilo
May 7, 2013·Cardiovascular Diabetology·Anna CabréLluís Masana
Mar 5, 2013·Heart Failure Reviews·Mauricio VelezHani N Sabbah
Jan 28, 2014·Pharmacology & Therapeutics·Karina HuynhRebecca H Ritchie
Sep 22, 2012·Biochemical and Biophysical Research Communications·Jiang-Wen LiuYing Su
Jun 28, 2011·International Journal of Cardiology·Ri-Ning TangBi-Cheng Liu
Aug 24, 2010·Journal of Molecular and Cellular Cardiology·Sharon EtzionAnthony J Muslin
Jul 9, 2010·Journal of Cardiac Failure·Hillary R BognerRavishankar Jayadevappa
Nov 17, 2009·Nitric Oxide : Biology and Chemistry·John W Calvert, David J Lefer
Sep 18, 2015·European Journal of Heart Failure·Michel KomajdaUNKNOWN SHIFT Investigators
Sep 10, 2011·European Journal of Clinical Investigation·Savina NodariAlessandra Dei Cas
Jul 22, 2014·Journal of Cardiac Surgery·Kamel SadatWissam I Khalife
Mar 18, 2010·Clinical Cardiology·Mikhael F El-ChamiAngel R Leon
Jul 11, 2012·The International Journal of Biochemistry & Cell Biology·Catia V DiogoMariusz R Wieckowski
Feb 13, 2015·Antioxidants & Redox Signaling·Miguel A AonSonia Cortassa
Mar 27, 2015·Antioxidants & Redox Signaling·Miranda M SungJason R B Dyck
Jan 25, 2011·Biochimica Et Biophysica Acta·Jennifer G Duncan
Nov 7, 2017·Sensors·Rocio B DominguezAlfredo Márquez-Lucero
Feb 15, 2014·Circulation Research·David J Polhemus, David J Lefer
Jul 3, 2013·Circulation. Heart Failure·David J PolhemusJohn W Calvert
Apr 10, 2015·PLoS Computational Biology·Peter KlimekStefan Thurner
Feb 20, 2015·PloS One·Akiko NanriUNKNOWN Japan Public Health Center-Based Prospective Study Group
Feb 22, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Loubina FazalJane-Lise Samuel
Sep 9, 2017·Journal of Applied Physiology·Dalila BoudiaJane-Lise Samuel
May 22, 2020·Circulation Research·Rebecca H Ritchie, E Dale Abel
Nov 14, 2019·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Koh OnoUNKNOWN ABLE-MET Investigators
Mar 21, 2017·International Journal of Endocrinology·Paola BallotariValeria Manicardi
Feb 21, 2019·Experimental and Therapeutic Medicine·Yao-Meng HuangBing-Hui Li
Sep 26, 2020·Frontiers in Medicine·Vinaya Mulkareddy, Marc A Simon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.